Table 4 Patient and donor demographics for Fig. 5k.
From: Obesity-induced galectin-9 is a therapeutic target in B-cell acute lymphoblastic leukemia
All Patients | BMI-5th and 85th Percentile (calculated using weight/height/age) | BMI ≥ 95th Percentile (calculated using weight/height/age) | P value | ||||
|---|---|---|---|---|---|---|---|
Characteristic | No. | % | No. | % | No. | % | |
Leukemia Present | 0.361 | ||||||
Yes | 10 | 50.0 | 3 | 37.0 | 7 | 58.0 | |
No | 10 | 50.0 | 5 | 63.0 | 5 | 42.0 | |
Age (years) | 0.575 | ||||||
Mean ± SD | 19.4 ± 6.9 | 18.3 ± 5.9 | 20.1 ± 7.7 | ||||
Range | 11.5–36 | 11.5–25 | 13.2–36 | ||||
Gender | 0.848 | ||||||
Male | 7 | 35.0 | 3 | 38% | 4 | 33% | |
Female | 13 | 65.0 | 5 | 62% | 8 | 67% | |
Race | 0.201 | ||||||
Caucasian | 13 | 65.0 | 7 | 88.0 | 6 | 50.0 | |
African American | 5 | 25.0 | 1 | 12.0 | 4 | 33.0 | |
Other | 2 | 10.0 | 0 | 0.0 | 2 | 17.0 | |
